Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceDE GIORGI, U; DEMIRER, T; WANDT, H et al.Annals of oncology. 2005, Vol 16, Num 1, pp 146-151, issn 0923-7534, 6 p.Article

Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatmentRAMOS, M; GONZALEZ-AGEITOS, A; AMENEDO, M et al.Journal of chemotherapy. 2003, Vol 15, Num 2, pp 192-197, issn 1120-009X, 6 p.Article

Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapyNATHER, Andreas; MAYERHOFER, Klaus; GRIMM, Christoph et al.Anticancer research. 2003, Vol 23, Num 3C, pp 2991-2994, issn 0250-7005, 4 p.Article

Second-line chemotherapy for patients with advanced gastric cancer : who may benefit?CATALANO, V; GRAZIANO, F; TONINI, G et al.British journal of cancer. 2008, Vol 99, Num 9, pp 1402-1407, issn 0007-0920, 6 p.Article

Unresectable alpha fetoprotein-producing gastric cancer successfully treated with irinotecan and mitomycin C after S-1 failureHIRAO, Ken; HIRASAKI, Shoji; TSUZUKI, Takao et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 2, pp 106-110, issn 0918-2918, 5 p.Article

Second-Line Docetaxel plus Cisplatin for Advanced Gastric Cancer Showing Resistance to S-1TAKAGAWA, R; KUNISAKI, C; MAKINO, H et al.Journal of chemotherapy (Testo stampato). 2011, Vol 23, Num 1, pp 44-48, issn 1120-009X, 5 p.Article

Gemcitabine and Vinorelbine in Pemetrexed-Pretreated Patients With Malignant Pleural MesotheliomaZUCALI, Paolo A; CERESOLI, Giovanni L; GARASSINO, Isabella et al.Cancer. 2008, Vol 112, Num 7, pp 1555-1561, issn 0008-543X, 7 p.Article

Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer : A phase II studyROSATI, G; BILANCIA, D; GERMANO, D et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi128-vi132, SUP6Conference Paper

Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?ODRAZKA, Karel; VACULIKOVA, Miloslava; DOLEZEL, Martin et al.Oncology reports. 2005, Vol 14, Num 4, pp 1077-1081, issn 1021-335X, 5 p.Article

Performance Status and Sensitivity to First-line Chemotherapy Are Significant Prognostic Factors in Patients With Recurrent Small Cell Lung Cancer Receiving Second-line ChemotherapyYOUNG HAK KIM; GOTO, Koichi; YOH, Kiyotaka et al.Cancer. 2008, Vol 113, Num 9, pp 2518-2523, issn 0008-543X, 6 p.Article

Optimal dose-finding study of Bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancerKOIZUMI, Wasaburo; TANABE, Satoshi; HIGUCHI, Katsuhiko et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3797-3802, issn 0250-7005, 6 p.Article

A Retrospective Analysis of Non-platinum-based First- and Second-line Chemotherapy in Patients with Advanced Non-small Cell Lung CancerKOTSAKIS, Athanasios; HATZIDAKI, Dora; AGELAKI, Sophia et al.Anticancer research. 2010, Vol 30, Num 10, pp 4335-4342, issn 0250-7005, 8 p.Article

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcomaREICHARDT, Peter; OECHSLE, Karin; PINK, Daniel et al.Investigational new drugs. 2003, Vol 21, Num 4, pp 481-486, issn 0167-6997, 6 p.Article

Evaluation of Oral Etoposide in Combination with Cisplatin for Patients with Recurrent Cervical Cancer: Long-term Follow-up Results of a Japanese Multicenter StudyWATANABE, Yoh; HOSHIAI, Hiroshi; NAKANISHI, Toru et al.Anticancer research. 2011, Vol 31, Num 9, pp 3063-3067, issn 0250-7005, 5 p.Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer : An analysis of results in clinical practice of the gruppo oncologico italia meridionale (GOIM)GEBBIA, Vittorio; CARUSO, Michele; BAJARDI, Eugenia et al.Anticancer research. 2006, Vol 26, Num 4B, pp 3143-3150, issn 0250-7005, 8 p.Article

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentWACHTERS, F. M; GROEN, H. J. M; BIESMA, B et al.British journal of cancer. 2005, Vol 92, Num 1, pp 15-20, issn 0007-0920, 6 p.Article

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versaBERTHOLD, D. R; POND, G. R; DE WIT, R et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1749-1753, issn 0923-7534, 5 p.Article

Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinomaKUNISAKI, Chikara; IMADA, Toshio; SHIMADA, Hiroshi et al.Anticancer research. 2005, Vol 25, Num 4, pp 2973-2977, issn 0250-7005, 5 p.Article

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyBIDARD, F.-C; TOURNIGAND, C; DE GRAMONT, A et al.Annals of oncology. 2009, Vol 20, Num 6, pp 1042-1047, issn 0923-7534, 6 p.Article

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104)TAKEDA, K; NEGORO, S; ANDO, M et al.Annals of oncology. 2009, Vol 20, Num 5, pp 835-841, issn 0923-7534, 7 p.Article

A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineDONGIOVANNI, Vincenzo; ADDEO, Alfredo; BERRUTI, Alfredo et al.Anticancer research. 2004, Vol 24, Num 4, pp 2567-2572, issn 0250-7005, 6 p.Article

Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancerBAMIAS, A; PAPAMICHAEL, D; SYRIGOS, K et al.Journal of chemotherapy. 2003, Vol 15, Num 3, pp 275-281, issn 1120-009X, 7 p.Article

Trastuzumab beyond progression: a cost-utility analysisMATTER-WALSTRA, K. W; DEDES, K. J; SCHWENKGLENKS, M et al.Annals of oncology. 2010, Vol 21, Num 11, pp 2161-2168, issn 0923-7534, 8 p.Article

Multicentre phase II study of bifractionated CPT-II with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOXRECCHIA, F; SAGGIO, G; NUZZO, A et al.British journal of cancer. 2004, Vol 91, Num 8, pp 1442-1446, issn 0007-0920, 5 p.Article